imipenem, anhydrous has been researched along with Joint Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anoushiravani, A; Farsad, K; Gabr, A; Horikawa, M; Jahangiri, Y; Kumagai, K; Li, J; Uchida, B; Yamada, K | 1 |
| Dretler, RH; Job, ML | 1 |
2 other study(ies) available for imipenem, anhydrous and Joint Diseases
| Article | Year |
|---|---|
Embolic Characteristics of Imipenem-Cilastatin Particles in Vitro and in Vivo: Implications for Transarterial Embolization in Joint Arthropathies.
Topics: Animals; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Therapy, Combination; Imipenem; Joint Diseases; Male; Rats; Rats, Sprague-Dawley | 2021 |
Seizure activity with imipenem therapy: incidence and risk factors.
Topics: Aged; Aged, 80 and over; Bacterial Infections; Humans; Imipenem; Joint Diseases; Knee Joint; Male; Pneumonia; Risk Factors; Seizures | 1990 |